Covered recipient · General Payments record
LISA R LAFATA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$209.14
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $196.42 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $108.01 | 6 |
| Acerta Pharma LLC | $42.49 | 2 |
| Lilly USA, LLC | $32.58 | 2 |
| Exact Sciences Corporation | $13.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $17.14 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105493403 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.35 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105881410 | CMS |
| Exact Sciences Corporation | $13.34 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114546408 | CMS |
| Lilly USA, LLC | $14.45 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135802034 | CMS |
| Lilly USA, LLC | $18.13 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135767049 | CMS |
| Novo Nordisk Inc | $16.54 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100487495 | CMS |
| Novo Nordisk Inc | $19.10 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100439303 | CMS |
| Novo Nordisk Inc | $20.32 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100571476 | CMS |
| Novo Nordisk Inc | $17.57 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100343896 | CMS |
| Novo Nordisk Inc | $15.25 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100599601 | CMS |
| Novo Nordisk Inc | $19.23 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100376949 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.